Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: On Friday the topic of 17.7 million share increase for institutional

On Friday the topic of 17.7 million share increase for institutional

posted on Oct 08, 2007 04:13AM

investment in PTSC was reported by MSN money(over the last 3 months).... That to me seems big..... could not confirm those #'s.... but we need some retail & Institutional investor to have this take off... we also need it to get above $1.....

 

Share
New Message
Please login to post a reply